These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts. Trueblood B; Judson BA; Goldstein A Drug Alcohol Depend; 1978 Mar; 3(2):125-32. PubMed ID: 631012 [TBL] [Abstract][Full Text] [Related]
4. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction. Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939 [TBL] [Abstract][Full Text] [Related]
5. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts. Freedman RR; Czertko G Drug Alcohol Depend; 1981 Nov; 8(3):215-22. PubMed ID: 7327086 [TBL] [Abstract][Full Text] [Related]
7. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence. Blaine JD NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis. Newcombe DA; Bochner F; White JM; Somogyi AA Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290 [TBL] [Abstract][Full Text] [Related]
9. Phase III clinical study of levo-alpha-acetylmethadol. Whysner JA NIDA Res Monogr; 1976 Jul; (8):109-11. PubMed ID: 792694 [No Abstract] [Full Text] [Related]
10. Effects of acetylmethadol on plasma testosterone. Mendelson JH; Inturrisi CE; Renault P; Senay EC Clin Pharmacol Ther; 1976 Mar; 19(3):371-4. PubMed ID: 1261171 [TBL] [Abstract][Full Text] [Related]
11. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction. Marcovici M; O'Brien CP; McLellan AT; Kacian J Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647 [TBL] [Abstract][Full Text] [Related]
12. Problems of methadone diversion and implications for control. Resnick RB Int J Addict; 1977 Oct; 12(7):803-6. PubMed ID: 591140 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of methadone and 1-alpha-acetylmethadol. Karp-Gelernter E; Wurmser L; Savage C Am J Psychiatry; 1976 Aug; 133(8):955-7. PubMed ID: 942010 [TBL] [Abstract][Full Text] [Related]
14. Effects of LAAM and methadone utilization in an opiate agonist treatment program. Valdivia JF; Khattak S Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490 [TBL] [Abstract][Full Text] [Related]
15. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog. Vaupel DB; Jasinski DR J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405 [TBL] [Abstract][Full Text] [Related]
16. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization. Judson BA; Goldstein A Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680 [TBL] [Abstract][Full Text] [Related]
17. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions. Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673 [TBL] [Abstract][Full Text] [Related]
18. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration. Henderson GL; Wilson BK; Lau DH Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446 [TBL] [Abstract][Full Text] [Related]
19. Levo-alpha-acetylmethadol: new drug for old habits. Ling W NIDA Res Monogr; 1978; (19):242-8. PubMed ID: 106288 [No Abstract] [Full Text] [Related]
20. l-alpha-acetylmethadol and methadone in Buffalo: safety and efficacy. Taintor Z; Hough G; Plumb M; Murphy BF Am J Drug Alcohol Abuse; 1975; 2(3-4):317-30. PubMed ID: 1227293 [No Abstract] [Full Text] [Related] [Next] [New Search]